Ivermectin: Oxford University to Trial Promising, Easily Available Drug as Early Treatment for COVID-19
The Principle trial at Oxford University has selected Ivermectin for inclusion in its study of repurposed drugs for COVID-19, meaning 14 months after its potential was discovered the drug might finally be approved.
